Clinical Care Pathway for the Risk Stratification and Management of Patients With Nonalcoholic Fatty Liver Disease
Fasiha Kanwal(Michael E. DeBakey VA Medical Center), Kenneth Cusi(University of Florida), Hashem B. El‐Serag(Baylor College of Medicine), Kim Pfotenhauer(Michigan State University), Jay H. Shubrook(Touro University California), Elisabetta Bugianesi(University of Turin), Rohit Loomba(University of California San Diego), Eugene E. Wright(Duke University), Lee M. Kaplan(Dartmouth College), Robert H. Eckel(University of Colorado Anschutz Medical Campus), Leon A. Adams(The University of Western Australia), Stephen A. Harrison(Pinnacle Clinical Research), Christos S. Mantzoros(Beth Israel Deaconess Medical Center), Vincent Wai‐Sun Wong(Chinese University of Hong Kong), Manal F. Abdelmalek(Mayo Clinic)
Cited by 577
Related Papers
Role of leptin in the neuroendocrine response to fasting
|Nature|1996|3.1k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Hepatology|2023|2.9k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Journal of Hepatology|2023|2.7k
Adverse metabolic and cardiovascular consequences of circadian misalignment
|Proceedings of the National Academy of Sciences|2009|2.3k